HuidaGene Therapeutics Co., Ltd.
HuidaGene Therapeutics Co., Ltd.
Explore linked clinical trials.6 results ยท Page 1 of 1
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| An Open-label, Multidose Dose-escalation Study to Understand the Safety of CRISPR Gene-editing Therapy and Its Long-Lasting Effects in DMD Patients (MUSCLE) | Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Duchenne muscular dystrophy, Muscular Disorders, Atrophic, X-linked disease, hereditary disease, muscle tissue disorder, muscular dystrophy, musculoskeletal system disorder, nervous system disorder, neuromuscular disease | Active, not recruiting | Early phase 1 | 2026-08-03 | NCT06594094 | |
| An Clinical Study Evaluating the Safety, Tolerability, and efficAcy of HG005 in StaRgardT Disease | Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Eye Diseases, Hereditary, Stargardt disease, eye disorder, hereditary disease, macular degeneration, retinal degeneration, retinal disorder | Recruiting | Early phase 1 | 2025-08-27 | NCT07063251 | |
| CRISPR/cas13-medIated RNA TarGeting THerapy for the Treatment of Neovascular Age-related Macular Degeneration Investigator-initiated Trial (SIGHT-I) | Neovascular Age-related Macular Degeneration(nAMD) | Recruiting | Early phase 1 | 2025-03-17 | NCT06031727 | |
| A First-in-Human Clinical Trial to Evaluate the Safety, Tolerability, and Efficacy of a Novel CRISPR RNA-editing Therapy in Patients with Mecp2 Duplication Syndrome, a Rare Orphan Disease (HERO) | syndromic X-linked intellectual disability Lubs type | Recruiting | Not applicable | 2024-11-26 | NCT06615206 | |
| Open-laBel Dose-escalation Study for CRISPR/cas13- Rna TargetInG THerapy for the Treatment of Neovascular Age-related Macular Degeneration in Phase I Trial | eye disorder, macular degeneration, retinal degeneration, retinal disorder | Not yet recruiting | Phase 1 | 2024-10-02 | NCT06623279 | |
| Leber Congenital Amaurosis Inherited Blindness of Gene Therapy Trial(LIGHT) | Eye Diseases, Hereditary, Leber congenital amaurosis, eye disorder, retinal disorder | Active, not recruiting | Early phase 1 | 2024-09-19 | NCT06088992 |